{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:11:19Z","timestamp":1793412679119,"version":"4.5.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T00:00:00Z","timestamp":1445472000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s12016-015-8518-3","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T09:19:50Z","timestamp":1445591990000},"page":"263-270","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":81,"title":["Ocular Involvement in Systemic Autoimmune Diseases"],"prefix":"10.1007","volume":"49","author":[{"given":"Elena","family":"Generali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cantarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,10,22]]},"reference":[{"key":"8518_CR1","doi-asserted-by":"crossref","unstructured":"Gaubitz M (2006) Epidemiology of connective tissue disorders. Rheumatology (Oxford) 45 Suppl 3:iii3-4. doi: 10.1093\/rheumatology\/kel282","DOI":"10.1093\/rheumatology\/kel282"},{"issue":"6\u20137","key":"8518_CR2","doi-asserted-by":"crossref","first-page":"A531","DOI":"10.1016\/j.autrev.2011.11.024","volume":"11","author":"C Selmi","year":"2012","unstructured":"Selmi C, Brunetta E, Raimondo MG, Meroni PL (2012) The X chromosome and the sex ratio of autoimmunity. Autoimmun Rev 11(6\u20137):A531\u2013537. doi: 10.1016\/j.autrev.2011.11.024","journal-title":"Autoimmun Rev"},{"issue":"5","key":"8518_CR3","doi-asserted-by":"crossref","first-page":"A247","DOI":"10.1016\/j.autrev.2010.02.004","volume":"9","author":"C Selmi","year":"2010","unstructured":"Selmi C (2010) The worldwide gradient of autoimmune conditions. Autoimmun Rev 9(5):A247\u2013250. doi: 10.1016\/j.autrev.2010.02.004","journal-title":"Autoimmun Rev"},{"issue":"9451","key":"8518_CR4","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(04)17554-5","volume":"364","author":"P McCluskey","year":"2004","unstructured":"McCluskey P, Powell RJ (2004) The eye in systemic inflammatory diseases. Lancet 364(9451):2125\u20132133. doi: 10.1016\/S0140-6736(04)17554-5","journal-title":"Lancet"},{"key":"8518_CR5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.jaut.2014.01.027","volume":"48\u201349","author":"M Kourilovitch","year":"2014","unstructured":"Kourilovitch M, Galarza-Maldonado C, Ortiz-Prado E (2014) Diagnosis and classification of rheumatoid arthritis. J Autoimmun 48\u201349:26\u201330. doi: 10.1016\/j.jaut.2014.01.027","journal-title":"J Autoimmun"},{"issue":"7","key":"8518_CR6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1007\/s10067-015-2920-3","volume":"34","author":"V Bascherini","year":"2015","unstructured":"Bascherini V, Granato C, Lopalco G, Emmi G, Vannozzi L, Bacherini D, Franceschini R, Iannone F, Salerni A, Molinaro F, Messina M, Frediani B, Selmi C, Rigante D, Cantarini L (2015) The protean ocular involvement in monogenic autoinflammatory diseases: state of the art. Clin Rheumatol 34(7):1171\u20131180. doi: 10.1007\/s10067-015-2920-3","journal-title":"Clin Rheumatol"},{"issue":"3","key":"8518_CR7","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1111\/j.1756-185X.2010.01478.x","volume":"13","author":"S Kobak","year":"2010","unstructured":"Kobak S, Deveci H (2010) Retinopathy due to antimalarial drugs in patients with connective tissue diseases: are they so innocent? A single center retrospective study. Int J Rheum Dis 13(3):e11\u201315. doi: 10.1111\/j.1756-185X.2010.01478.x","journal-title":"Int J Rheum Dis"},{"issue":"8","key":"8518_CR8","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/sj.eye.6700617","volume":"17","author":"EK Akpek","year":"2003","unstructured":"Akpek EK, Gottsch JD (2003) Immune defense at the ocular surface. Eye (Lond) 17(8):949\u2013956. doi: 10.1038\/sj.eye.6700617","journal-title":"Eye (Lond)"},{"key":"8518_CR9","doi-asserted-by":"crossref","unstructured":"Zhou R, Caspi RR (2010) Ocular immune privilege. F1000 Biol Rep 2. doi:10.3410\/B2-3","DOI":"10.3410\/B2-3"},{"key":"8518_CR10","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jaut.2013.06.011","volume":"45","author":"VL Perez","year":"2013","unstructured":"Perez VL, Saeed AM, Tan Y, Urbieta M, Cruz-Guilloty F (2013) The eye: a window to the soul of the immune system. J Autoimmun 45:7\u201314. doi: 10.1016\/j.jaut.2013.06.011","journal-title":"J Autoimmun"},{"issue":"9","key":"8518_CR11","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/nrrheum.2014.85","volume":"10","author":"L Tong","year":"2014","unstructured":"Tong L, Thumboo J, Tan YK, Wong TY, Albani S (2014) The eye: a window of opportunity in rheumatoid arthritis? Nat Rev Rheumatol 10(9):552\u2013560. doi: 10.1038\/nrrheum.2014.85","journal-title":"Nat Rev Rheumatol"},{"issue":"88","key":"8518_CR12","first-page":"153","volume":"16","author":"D Wakefield","year":"2013","unstructured":"Wakefield D, Di Girolamo N, Thurau S, Wildner G, McCluskey P (2013) Scleritis: challenges in immunopathogenesis and treatment. Discov Med 16(88):153\u2013157","journal-title":"Discov Med"},{"key":"8518_CR13","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","volume":"48\u201349","author":"A Kuhn","year":"2014","unstructured":"Kuhn A, Landmann A (2014) The classification and diagnosis of cutaneous lupus erythematosus. J Autoimmun 48\u201349:14\u201319. doi: 10.1016\/j.jaut.2014.01.021","journal-title":"J Autoimmun"},{"issue":"2","key":"8518_CR14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000430490","volume":"6","author":"H Aoki","year":"2015","unstructured":"Aoki H, Hiraoka M, Hashimoto M, Ohguro H (2015) Systemic cyclosporine therapy for scleritis: a proposal of a novel system to assess the activity of scleritis. Case Rep Ophthalmol 6(2):149\u2013157. doi: 10.1159\/000430490","journal-title":"Case Rep Ophthalmol"},{"issue":"5","key":"8518_CR15","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1001\/jamaophthalmol.2013.8179","volume":"132","author":"EB Suhler","year":"2014","unstructured":"Suhler EB, Lim LL, Beardsley RM, Giles TR, Pasadhika S, Lee ST, de Saint SA, Butler NJ, Smith JR, Rosenbaum JT (2014) Rituximab therapy for refractory orbital inflammation: results of a phase 1\/2, dose-ranging, randomized clinical trial. JAMA Ophthalmol 132(5):572\u2013578. doi: 10.1001\/jamaophthalmol.2013.8179","journal-title":"JAMA Ophthalmol"},{"key":"8518_CR16","author":"A Sauer","year":"2015","unstructured":"Sauer A, Meyer N, Bourcier T, French Study Group for Contact Lens-Related Microbial K (2015) Risk factors for contact lens-related microbial keratitis: a case\u2013control multicenter study. Eye Contact Lens. doi: 10.1097\/ICL.0000000000000180","journal-title":"Eye Contact Lens"},{"key":"8518_CR17","doi-asserted-by":"crossref","first-page":"747","DOI":"10.2147\/OPTH.S24947","volume":"6","author":"A Yagci","year":"2012","unstructured":"Yagci A (2012) Update on peripheral ulcerative keratitis. Clin Ophthalmol 6:747\u2013754. doi: 10.2147\/OPTH.S24947","journal-title":"Clin Ophthalmol"},{"issue":"5","key":"8518_CR18","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.clindermatol.2015.05.004","volume":"33","author":"E Generali","year":"2015","unstructured":"Generali E, Ceribelli A, Massarotti M, Cantarini L, Selmi C (2015) Seronegative reactive spondyloarthritis and the skin. Clin Dermatol 33(5):531\u2013537. doi: 10.1016\/j.clindermatol.2015.05.004","journal-title":"Clin Dermatol"},{"key":"8518_CR19","doi-asserted-by":"crossref","first-page":"451675","DOI":"10.1155\/2015\/451675","volume":"2015","author":"C Rotondo","year":"2015","unstructured":"Rotondo C, Lopalco G, Iannone F, Vitale A, Talarico R, Galeazzi M, Lapadula G, Cantarini L (2015) Mucocutaneous involvement in Behcet\u2019s disease: how systemic treatment has changed in the last decades and future perspectives. Mediators Inflamm 2015:451675. doi: 10.1155\/2015\/451675","journal-title":"Mediators Inflamm"},{"key":"8518_CR20","author":"I Foeldvari","year":"2014","unstructured":"Foeldvari I (2014) Ocular involvement in juvenile idiopathic arthritis: classification and treatment. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-014-8436-9","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4\u20135","key":"8518_CR21","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.autrev.2014.01.006","volume":"13","author":"C Selmi","year":"2014","unstructured":"Selmi C (2014) Diagnosis and classification of autoimmune uveitis. Autoimmun Rev 13(4\u20135):591\u2013594. doi: 10.1016\/j.autrev.2014.01.006","journal-title":"Autoimmun Rev"},{"key":"8518_CR22","author":"SS Prabhu","year":"2015","unstructured":"Prabhu SS, Shtein RM, Michelotti MM, Cooney TM (2015) Topical cyclosporine A 0.05% for recurrent anterior uveitis. Br J Ophthalmol. doi: 10.1136\/bjophthalmol-2015-307251","journal-title":"Br J Ophthalmol"},{"key":"8518_CR23","author":"M Cordero-Coma","year":"2015","unstructured":"Cordero-Coma M, Sobrin L (2015) Anti-tumor necrosis factor-alpha therapy in uveitis. Surv Ophthalmol. doi: 10.1016\/j.survophthal.2015.06.004","journal-title":"Surv Ophthalmol"},{"issue":"3","key":"8518_CR24","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.ophtha.2013.09.048","volume":"121","author":"G Levy-Clarke","year":"2014","unstructured":"Levy-Clarke G, Jabs DA, Read RW, Rosenbaum JT, Vitale A, Van Gelder RN (2014) Expert panel recommendations for the use of anti-tumor necrosis factor biologic agents in patients with ocular inflammatory disorders. Ophthalmology 121(3):785\u2013796. doi: 10.1016\/j.ophtha.2013.09.048 , e783","journal-title":"Ophthalmology"},{"issue":"4 Suppl 84","key":"8518_CR25","first-page":"S54","volume":"32","author":"V Calvo-Rio","year":"2014","unstructured":"Calvo-Rio V, de la Hera D, Beltran-Catalan E, Blanco R, Hernandez M, Martinez-Costa L, Loricera J, Canal J, Ventosa J, Ortiz-Sanjuan F, Pina T, Gonzalez-Vela MC, Rodriguez-Cundin P, Gonzalez-Gay MA (2014) Tocilizumab in uveitis refractory to other biologic drugs: a study of 3 cases and a literature review. Clin Exp Rheumatol 32(4 Suppl 84):S54\u201357","journal-title":"Clin Exp Rheumatol"},{"key":"8518_CR26","author":"S Schwartzman","year":"2014","unstructured":"Schwartzman S, Schwartzman M (2014) The use of biologic therapies in uveitis. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-014-8455-6","journal-title":"Clin Rev Allergy Immunol"},{"issue":"1","key":"8518_CR27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s10067-012-2078-1","volume":"32","author":"S Androudi","year":"2013","unstructured":"Androudi S, Dastiridou A, Symeonidis C, Kump L, Praidou A, Brazitikos P, Kurup SK (2013) Retinal vasculitis in rheumatic diseases: an unseen burden. Clin Rheumatol 32(1):7\u201313. doi: 10.1007\/s10067-012-2078-1","journal-title":"Clin Rheumatol"},{"issue":"1","key":"8518_CR28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","volume":"65","author":"JC Jennette","year":"2013","unstructured":"Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, Flores-Suarez LF, Gross WL, Guillevin L, Hagen EC, Hoffman GS, Jayne DR, Kallenberg CG, Lamprecht P, Langford CA, Luqmani RA, Mahr AD, Matteson EL, Merkel PA, Ozen S, Pusey CD, Rasmussen N, Rees AJ, Scott DG, Specks U, Stone JH, Takahashi K, Watts RA (2013) 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65(1):1\u201311. doi: 10.1002\/art.37715","journal-title":"Arthritis Rheum"},{"key":"8518_CR29","author":"MS Chimenti","year":"2014","unstructured":"Chimenti MS, Ballanti E, Triggianese P, Perricone R (2014) Vasculitides and the complement system: a comprehensive review. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-014-8453-8","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2 Suppl 89","key":"8518_CR30","first-page":"S-84","volume":"33","author":"C Grossman","year":"2015","unstructured":"Grossman C, Barshack I, Bornstein G, Ben-Zvi I (2015) Is temporal artery biopsy essential in all cases of suspected giant cell arteritis? Clin Exp Rheumatol 33(2 Suppl 89):S-84\u201389","journal-title":"Clin Exp Rheumatol"},{"key":"8518_CR31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2014.01.017","volume":"48\u201349","author":"G Nesher","year":"2014","unstructured":"Nesher G (2014) The diagnosis and classification of giant cell arteritis. J Autoimmun 48\u201349:73\u201375. doi: 10.1016\/j.jaut.2014.01.017","journal-title":"J Autoimmun"},{"issue":"2 Suppl 89","key":"8518_CR32","first-page":"S-113","volume":"33","author":"M Aschwanden","year":"2015","unstructured":"Aschwanden M, Imfeld S, Staub D, Baldi T, Walker UA, Berger CT, Hess C, Daikeler T (2015) The ultrasound compression sign to diagnose temporal giant cell arteritis shows an excellent interobserver agreement. Clin Exp Rheumatol 33(2 Suppl 89):S-113\u2013115","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"8518_CR33","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11926-015-0527-y","volume":"17","author":"A Khan","year":"2015","unstructured":"Khan A, Dasgupta B (2015) Imaging in giant cell arteritis. Curr Rheumatol Rep 17(8):527. doi: 10.1007\/s11926-015-0527-y","journal-title":"Curr Rheumatol Rep"},{"issue":"25","key":"8518_CR34","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1056\/NEJMra1413352","volume":"372","author":"V Biousse","year":"2015","unstructured":"Biousse V, Newman NJ (2015) Ischemic optic neuropathies. N Engl J Med 372(25):2428\u20132436. doi: 10.1056\/NEJMra1413352","journal-title":"N Engl J Med"},{"issue":"6","key":"8518_CR35","doi-asserted-by":"crossref","first-page":"484","DOI":"10.12998\/wjcc.v3.i6.484","volume":"3","author":"C Ponte","year":"2015","unstructured":"Ponte C, Rodrigues AF, O\u2019Neill L, Luqmani RA (2015) Giant cell arteritis: current treatment and management. World J Clin Cases 3(6):484\u2013494. doi: 10.12998\/wjcc.v3.i6.484","journal-title":"World J Clin Cases"},{"key":"8518_CR36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.jaut.2014.03.002","volume":"50","author":"AL Calich","year":"2014","unstructured":"Calich AL, Puechal X, Pugnet G, London J, Terrier B, Charles P, Mouthon L, Guillevin L, French Vasculitis Study G (2014) Rituximab for induction and maintenance therapy in granulomatosis with polyangiitis (Wegener\u2019s). Results of a single-center cohort study on 66 patients. J Autoimmun 50:135\u2013141. doi: 10.1016\/j.jaut.2014.03.002","journal-title":"J Autoimmun"},{"issue":"2","key":"8518_CR37","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s40123-013-0016-1","volume":"2","author":"J Gu","year":"2013","unstructured":"Gu J, Zhou S, Ding R, Aizezi W, Jiang A, Chen J (2013) Necrotizing scleritis and peripheral ulcerative keratitis associated with Wegener\u2019s granulomatosis. Ophthalmol Ther 2(2):99\u2013111. doi: 10.1007\/s40123-013-0016-1","journal-title":"Ophthalmol Ther"},{"key":"8518_CR38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jaut.2014.01.018","volume":"48\u201349","author":"L Mouthon","year":"2014","unstructured":"Mouthon L, Dunogue B, Guillevin L (2014) Diagnosis and classification of eosinophilic granulomatosis with polyangiitis (formerly named Churg-Strauss syndrome). J Autoimmun 48\u201349:99\u2013103. doi: 10.1016\/j.jaut.2014.01.018","journal-title":"J Autoimmun"},{"issue":"3","key":"8518_CR39","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.rdc.2010.05.005","volume":"36","author":"AA Kubal","year":"2010","unstructured":"Kubal AA, Perez VL (2010) Ocular manifestations of ANCA-associated vasculitis. Rheum Dis Clin North Am 36(3):573\u2013586. doi: 10.1016\/j.rdc.2010.05.005","journal-title":"Rheum Dis Clin North Am"},{"key":"8518_CR40","author":"M Takeuchi","year":"2015","unstructured":"Takeuchi M, Kastner DL, Remmers EF (2015) The immunogenetics of Behcet\u2019s disease: a comprehensive review. J Autoimmun. doi: 10.1016\/j.jaut.2015.08.013","journal-title":"J Autoimmun"},{"issue":"8697","key":"8518_CR41","first-page":"1078","volume":"335","author":"Criteria for diagnosis of Behcet\u2019s disease","year":"1990","unstructured":"Criteria for diagnosis of Behcet\u2019s disease (1990) International study group for Behcet\u2019s Disease. Lancet 335(8697):1078\u20131080","journal-title":"Lancet"},{"key":"8518_CR42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jaut.2014.01.014","volume":"48\u201349","author":"H Yazici","year":"2014","unstructured":"Yazici H, Yazici Y (2014) Criteria for Behcet\u2019s disease with reflections on all disease criteria. J Autoimmun 48\u201349:104\u2013107. doi: 10.1016\/j.jaut.2014.01.014","journal-title":"J Autoimmun"},{"key":"8518_CR43","author":"Y Ozyazgan","year":"2014","unstructured":"Ozyazgan Y, Ucar D, Hatemi G, Yazici Y (2014) Ocular involvement of Behcet\u2019s syndrome: a comprehensive review. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-014-8425-z","journal-title":"Clin Rev Allergy Immunol"},{"key":"8518_CR44","first-page":"653539","volume":"2014","author":"UC Park","year":"2014","unstructured":"Park UC, Kim TW, Yu HG (2014) Immunopathogenesis of ocular Behcet\u2019s disease. J Immunol Res 2014:653539. doi: 10.1155\/2014\/653539","journal-title":"J Immunol Res"},{"key":"8518_CR45","doi-asserted-by":"crossref","first-page":"107421","DOI":"10.1155\/2014\/107421","volume":"2014","author":"F Caso","year":"2014","unstructured":"Caso F, Costa L, Rigante D, Lucherini OM, Caso P, Bascherini V, Frediani B, Cimaz R, Marrani E, Nieves-Martin L, Atteno M, Raffaele CG, Tarantino G, Galeazzi M, Punzi L, Cantarini L (2014) Biological treatments in Behcet\u2019s disease: beyond anti-TNF therapy. Mediators Inflamm 2014:107421. doi: 10.1155\/2014\/107421","journal-title":"Mediators Inflamm"},{"key":"8518_CR46","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jaut.2015.06.005","volume":"62","author":"H Vallet","year":"2015","unstructured":"Vallet H, Riviere S, Sanna A, Deroux A, Moulis G, Addimanda O, Salvarani C, Lambert M, Bielefeld P, Seve P, Sibilia J, Pasquali J, Fraison J, Marie I, Perard L, Bouillet L, Cohen F, Sene D, Schoindre Y, Lidove O, Le Hoang P, Hachulla E, Fain O, Mariette X, Papo T, Wechsler B, Bodaghi B, Rigon MR, Cacoub P, Saadoun D, French Behcet N (2015) Efficacy of anti-TNF alpha in severe and\/or refractory Behcet\u2019s disease: multicenter study of 124 patients. J Autoimmun 62:67\u201374. doi: 10.1016\/j.jaut.2015.06.005","journal-title":"J Autoimmun"},{"key":"8518_CR47","first-page":"CD010729","volume":"12","author":"F Nava","year":"2014","unstructured":"Nava F, Ghilotti F, Maggi L, Hatemi G, Del Bianco A, Merlo C, Filippini G, Tramacere I (2014) Biologics, colchicine, corticosteroids, immunosuppressants and interferon-alpha for Neuro-Behcet\u2019s Syndrome. Cochrane Database Syst Rev 12:CD010729. doi: 10.1002\/14651858.CD010729.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"8518_CR48","doi-asserted-by":"crossref","first-page":"781683","DOI":"10.1155\/2014\/781683","volume":"2014","author":"A Sharma","year":"2014","unstructured":"Sharma A, Hindman HB (2014) Aging: a predisposition to dry eyes. J Ophthalmol 2014:781683. doi: 10.1155\/2014\/781683","journal-title":"J Ophthalmol"},{"key":"8518_CR49","author":"D Cornec","year":"2014","unstructured":"Cornec D, Saraux A, Jousse-Joulin S, Pers JO, Boisrame-Gastrin S, Renaudineau Y, Gauvin Y, Roguedas-Contios AM, Genestet S, Chastaing M, Cochener B, Devauchelle-Pensec V (2014) The differential diagnosis of dry eyes, dry mouth, and parotidomegaly: a comprehensive review. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-014-8431-1","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"8518_CR50","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1007\/s10792-014-9969-x","volume":"34","author":"A Yagci","year":"2014","unstructured":"Yagci A, Gurdal C (2014) The role and treatment of inflammation in dry eye disease. Int Ophthalmol 34(6):1291\u20131301. doi: 10.1007\/s10792-014-9969-x","journal-title":"Int Ophthalmol"},{"issue":"2","key":"8518_CR51","first-page":"240","volume":"9","author":"M Hessen","year":"2014","unstructured":"Hessen M, Akpek EK (2014) Dry eye: an inflammatory ocular disease. J Ophthalmic Vis Res 9(2):240\u2013250","journal-title":"J Ophthalmic Vis Res"},{"key":"8518_CR52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jaut.2014.03.003","volume":"51","author":"S Colafrancesco","year":"2014","unstructured":"Colafrancesco S, Perricone C, Priori R, Valesini G, Shoenfeld Y (2014) Sjogren\u2019s syndrome: another facet of the autoimmune\/inflammatory syndrome induced by adjuvants (ASIA). J Autoimmun 51:10\u201316. doi: 10.1016\/j.jaut.2014.03.003","journal-title":"J Autoimmun"},{"key":"8518_CR53","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jaut.2014.02.006","volume":"51","author":"D Cornec","year":"2014","unstructured":"Cornec D, Jamin C, Pers JO (2014) Sjogren\u2019s syndrome: where do we stand, and where shall we go? J Autoimmun 51:109\u2013114. doi: 10.1016\/j.jaut.2014.02.006","journal-title":"J Autoimmun"},{"key":"8518_CR54","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.jaut.2014.01.013","volume":"48\u201349","author":"AV Goules","year":"2014","unstructured":"Goules AV, Tzioufas AG, Moutsopoulos HM (2014) Classification criteria of Sjogren\u2019s syndrome. J Autoimmun 48\u201349:42\u201345. doi: 10.1016\/j.jaut.2014.01.013","journal-title":"J Autoimmun"},{"issue":"2","key":"8518_CR55","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jtos.2014.12.001","volume":"13","author":"GN Foulks","year":"2015","unstructured":"Foulks GN, Forstot SL, Donshik PC, Forstot JZ, Goldstein MH, Lemp MA, Nelson JD, Nichols KK, Pflugfelder SC, Tanzer JM, Asbell P, Hammitt K, Jacobs DS (2015) Clinical guidelines for management of dry eye associated with Sjogren disease. Ocul Surf 13(2):118\u2013132. doi: 10.1016\/j.jtos.2014.12.001","journal-title":"Ocul Surf"},{"key":"8518_CR56","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.jaut.2013.12.010","volume":"51","author":"R Seror","year":"2014","unstructured":"Seror R, Theander E, Bootsma H, Bowman SJ, Tzioufas A, Gottenberg JE, Ramos-Casals M, Dorner T, Ravaud P, Mariette X, Vitali C (2014) Outcome measures for primary Sjogren\u2019s syndrome: a comprehensive review. J Autoimmun 51:51\u201356. doi: 10.1016\/j.jaut.2013.12.010","journal-title":"J Autoimmun"},{"key":"8518_CR57","author":"V Valim","year":"2014","unstructured":"Valim V, Trevisani VF, de Sousa JM, Vilela VS, Belfort R Jr (2014) Current approach to dry eye disease. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-014-8438-7","journal-title":"Clin Rev Allergy Immunol"},{"key":"8518_CR58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.4137\/OED.S16067","volume":"6","author":"C Schultz","year":"2014","unstructured":"Schultz C (2014) Safety and efficacy of cyclosporine in the treatment of chronic dry eye. Ophthalmol Eye Dis 6:37\u201342. doi: 10.4137\/OED.S16067","journal-title":"Ophthalmol Eye Dis"},{"issue":"3","key":"8518_CR59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jtos.2014.12.006","volume":"13","author":"KH Wan","year":"2015","unstructured":"Wan KH, Chen LJ, Young AL (2015) Efficacy and safety of topical 0.05% cyclosporine eye drops in the treatment of dry eye syndrome: a systematic review and meta-analysis. Ocul Surf 13(3):213\u2013225. doi: 10.1016\/j.jtos.2014.12.006","journal-title":"Ocul Surf"},{"key":"8518_CR60","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.12659\/MSM.891364","volume":"20","author":"A Liu","year":"2014","unstructured":"Liu A, Ji J (2014) Omega-3 essential fatty acids therapy for dry eye syndrome: a meta-analysis of randomized controlled studies. Med Sci Monit 20:1583\u20131589. doi: 10.12659\/MSM.891364","journal-title":"Med Sci Monit"},{"issue":"4","key":"8518_CR61","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/ICU.0000000000000169","volume":"26","author":"JL Alio","year":"2015","unstructured":"Alio JL, Rodriguez AE, WrobelDudzinska D (2015) Eye platelet-rich plasma in the treatment of ocular surface disorders. Curr Opin Ophthalmol 26(4):325\u2013332. doi: 10.1097\/ICU.0000000000000169","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"8518_CR62","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/ICU.0000000000000171","volume":"26","author":"JC Bavinger","year":"2015","unstructured":"Bavinger JC, DeLoss K, Mian SI (2015) Scleral lens use in dry eye syndrome. Curr Opin Ophthalmol 26(4):319\u2013324. doi: 10.1097\/ICU.0000000000000171","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"8518_CR63","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s10067-013-2226-2","volume":"32","author":"CR Stelton","year":"2013","unstructured":"Stelton CR, Connors DB, Walia SS, Walia HS (2013) Hydrochloroquine retinopathy: characteristic presentation with review of screening. Clin Rheumatol 32(6):895\u2013898. doi: 10.1007\/s10067-013-2226-2","journal-title":"Clin Rheumatol"},{"key":"8518_CR64","author":"N Costedoat-Chalumeau","year":"2015","unstructured":"Costedoat-Chalumeau N, Dunogue B, Leroux G, Morel N, Jallouli M, Le Guern V, Piette JC, Brezin AP, Melles RB, Marmor MF (2015) A critical review of the effects of hydroxychloroquine and chloroquine on the eye. Clin Rev Allergy Immunol. doi: 10.1007\/s12016-015-8469-8","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"8518_CR65","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.ophtha.2010.11.017","volume":"118","author":"MF Marmor","year":"2011","unstructured":"Marmor MF, Kellner U, Lai TY, Lyons JS, Mieler WF, American Academy of O (2011) Revised recommendations on screening for chloroquine and hydroxychloroquine retinopathy. Ophthalmology 118(2):415\u2013422. doi: 10.1016\/j.ophtha.2010.11.017","journal-title":"Ophthalmology"},{"issue":"6","key":"8518_CR66","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.ophtha.2015.02.011","volume":"122","author":"AC Tsang","year":"2015","unstructured":"Tsang AC, Ahmadi Pirshahid S, Virgili G, Gottlieb CC, Hamilton J, Coupland SG (2015) Hydroxychloroquine and chloroquine retinopathy: a systematic review evaluating the multifocal electroretinogram as a screening test. Ophthalmology 122(6):1239\u20131251. doi: 10.1016\/j.ophtha.2015.02.011 , e1234","journal-title":"Ophthalmology"},{"issue":"6","key":"8518_CR67","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s11926-015-0513-4","volume":"17","author":"E Harris","year":"2015","unstructured":"Harris E, Tiganescu A, Tubeuf S, Mackie SL (2015) The prediction and monitoring of toxicity associated with long-term systemic glucocorticoid therapy. Curr Rheumatol Rep 17(6):513. doi: 10.1007\/s11926-015-0513-4","journal-title":"Curr Rheumatol Rep"},{"issue":"2","key":"8518_CR68","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000328630","volume":"47","author":"MR Razeghinejad","year":"2012","unstructured":"Razeghinejad MR, Katz LJ (2012) Steroid-induced iatrogenic glaucoma. Ophthalmic Res 47(2):66\u201380. doi: 10.1159\/000328630","journal-title":"Ophthalmic Res"},{"issue":"3","key":"8518_CR69","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11882-012-0333-9","volume":"13","author":"A Gurbaxani","year":"2013","unstructured":"Gurbaxani A, Fraser CL, Skalicky SE, McCluskey P (2013) Ocular complications associated with systemic medications used in allergy\/immunology practice. Curr Allergy Asthma Rep 13(3):329\u2013335. doi: 10.1007\/s11882-012-0333-9","journal-title":"Curr Allergy Asthma Rep"},{"issue":"9","key":"8518_CR70","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s10067-012-2035-z","volume":"31","author":"I Hemmati","year":"2012","unstructured":"Hemmati I, Wade J, Kelsall J (2012) Risedronate-associated scleritis: a case report and review of the literature. Clin Rheumatol 31(9):1403\u20131405. doi: 10.1007\/s10067-012-2035-z","journal-title":"Clin Rheumatol"},{"issue":"2","key":"8518_CR71","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3816\/CLM.2006.n.053","volume":"7","author":"D Benderson","year":"2006","unstructured":"Benderson D, Karakunnel J, Kathuria S, Badros A (2006) Scleritis complicating zoledronic acid infusion. Clin Lymphoma Myeloma 7(2):145\u2013147. doi: 10.3816\/CLM.2006.n.053","journal-title":"Clin Lymphoma Myeloma"},{"issue":"1","key":"8518_CR72","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/1759720X14566424","volume":"7","author":"EM Clark","year":"2015","unstructured":"Clark EM, Durup D (2015) Inflammatory eye reactions with bisphosphonates and other osteoporosis medications: what are the risks? Ther Adv Musculoskelet Dis 7(1):11\u201316. doi: 10.1177\/1759720X14566424","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"8518_CR73","doi-asserted-by":"crossref","unstructured":"Lefebvre DR, Mandeville JT, Yonekawa Y, Arroyo JG, Torun N, Freitag SK (2015) A case series and review of bisphosphonate-associated orbital inflammation. Ocul Immunol Inflamm:1\u20136. doi:10.3109\/09273948.2014.942747","DOI":"10.3109\/09273948.2014.942747"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8518-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8518-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,31]],"date-time":"2019-08-31T21:05:31Z","timestamp":1567285531000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,22]]},"references-count":73,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["8518"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8518-3","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,22]]}}}